Видео ютуба по тегу Alzecure

AlzeCure - About Alzstatin
AlzeCure - About Alzstatin
Alzecure Pharma - VD intervju med Martin Jönsson om det andra kvartalet 2025.
Alzecure Pharma - VD intervju med Martin Jönsson om det andra kvartalet 2025.
AlzeCure Pharma´s event, Welcome address, agenda & company overview, – Martin Jönsson, CEO, AlzeCure
AlzeCure Pharma´s event, Welcome address, agenda & company overview, – Martin Jönsson, CEO, AlzeCure
AlzeCure´s CEO, Martin Jönsson at BioStock
AlzeCure´s CEO, Martin Jönsson at BioStock
AlzeCure Pharma - ACD440 - A novel non-opioid analgesic with Orphan Designation
AlzeCure Pharma - ACD440 - A novel non-opioid analgesic with Orphan Designation
An introduction to AlzeCure Pharma.
An introduction to AlzeCure Pharma.
We are AlzeCure
We are AlzeCure
AlzeCure Pharma company presentation in English_Aug. 17 2020
AlzeCure Pharma company presentation in English_Aug. 17 2020
Alzecure Pharma - Naventus Life Science Summit 2021
Alzecure Pharma - Naventus Life Science Summit 2021
AlzeCure Pharma CEO Martin on the Nordic Health Summit Japan
AlzeCure Pharma CEO Martin on the Nordic Health Summit Japan
AlzeCure Company Overview & Visions; September 1 2021
AlzeCure Company Overview & Visions; September 1 2021
AlzeCure - About Alzheimer's disease.
AlzeCure - About Alzheimer's disease.
Sitdown - Alzecure Pharma
Sitdown - Alzecure Pharma
Alzecure Pharma - VD Martin Jönsson om FDA-processen och Orphan Designation för ACD440
Alzecure Pharma - VD Martin Jönsson om FDA-processen och Orphan Designation för ACD440
AlzeCure Pharmas VD, Martin Jönsson hos BioStock - Framsteg & emissionen
AlzeCure Pharmas VD, Martin Jönsson hos BioStock - Framsteg & emissionen
AlzeCure- About NeuroRestore.
AlzeCure- About NeuroRestore.
Lilla lördag – AlzeCure Pharma
Lilla lördag – AlzeCure Pharma
AlzeCure hos Finwire - Om AlzeCures framtida pipeline
AlzeCure hos Finwire - Om AlzeCures framtida pipeline
AlzeCure Pharmas VD, Martin Jönsson och CSO Johan Sandin hos Redeye
AlzeCure Pharmas VD, Martin Jönsson och CSO Johan Sandin hos Redeye
AlzeCure Pharma - Sitdown AlzeCure Pharma, 18 januari, 2022
AlzeCure Pharma - Sitdown AlzeCure Pharma, 18 januari, 2022
AlzeCure hos Finwire - Q3 - Varför investera
AlzeCure hos Finwire - Q3 - Varför investera
AlzeCure hos Redeye–Indikerar möjligheter inom övervikt för NeuroRestore ACD856
AlzeCure hos Redeye–Indikerar möjligheter inom övervikt för NeuroRestore ACD856
AlzeCure Pharma – executive interview
AlzeCure Pharma – executive interview
We need to raise awareness – Follow AlzeCure and learn more about our research
We need to raise awareness – Follow AlzeCure and learn more about our research